Literature DB >> 15130285

Factors influencing nitroxide reduction and cytotoxicity in vitro.

Yuval Samuni1, Janet Gamson, Ayelet Samuni, Kenichi Yamada, Angelo Russo, Murali C Krishna, James B Mitchell.   

Abstract

Nitroxides have been shown to be effective antioxidants, radiation protectors, and redox-active probes for functional electron paramagnetic resonance (EPR) imaging. More recently, the nitroxide 4-hydroxy-2,2,6,6-tetramethylpiperidinyl-N-oxyl (Tempol) has been shown to exert differential cytotoxicity to tumor compared with normal cell counterparts. Nitroxides are readily reduced in tissues to their respective hydroxylamines, which exhibit less cytotoxicity in vitro and do not provide radiation protection or an EPR-detectable signal for imaging. In order to better understand factors that influence nitroxide reduction, the rate of reduction of Tempol in mouse and human cell lines and in primary cultures of tumor cells was measured using EPR spectroscopy. Additionally, the cytotoxicity of high concentrations of Tempol and the hydroxylamine of Tempol (Tempol-H) was evaluated in wild-type and glucose-6-phosphate dehydrogenase (G6PD)-deficient Chinese hamster ovary cells. The results show that in general Tempol was reduced at a faster rate when cells were under hypoxic compared with aerobic conditions. Neither depletion of intracellular glutathione nor treatment of cells with sodium cyanide influenced Tempol reduction rates. G6PD-deficient cells were found to reduce Tempol at a significantly slower rate than wild-type cells. Likewise, Tempol-induced cytotoxicity was markedly less for G6PD-deficient cells compared with wild-type cells. Tempol-H exhibited no cytotoxicity to either cell type. Tempol-mediated cytotoxicity was enhanced by glutathione depletion and inhibition of 6-phosphogluconate dehydrogenase in wild-type cells, but was unaltered in G6PD-deficient cells. Collectively, the results indicate that while the bioreduction of Tempol can be influenced by a number of factors, the hexose monophosphate shunt appears to be involved in both nitroxide reduction as well as cytotoxicity induced by high levels of exposure to Tempol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130285     DOI: 10.1089/152308604773934341

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  21 in total

1.  Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts.

Authors:  Karuppaiyah Selvendiran; Liyue Tong; Anna Bratasz; M Lakshmi Kuppusamy; Shabnam Ahmed; Yazhini Ravi; Nancy J Trigg; Brian K Rivera; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

2.  Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging.

Authors:  Molly A Sowers; Jessica R McCombs; Ying Wang; Joseph T Paletta; Stephen W Morton; Erik C Dreaden; Michael D Boska; M Francesca Ottaviani; Paula T Hammond; Andrzej Rajca; Jeremiah A Johnson
Journal:  Nat Commun       Date:  2014-11-18       Impact factor: 14.919

3.  A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector.

Authors:  Ryan M Davis; Anastasia L Sowers; William DeGraff; Marcelino Bernardo; Angela Thetford; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2011-05-25       Impact factor: 7.376

4.  Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells.

Authors:  Wilmarie Flores-Santana; Terry Moody; Weibin Chen; Michael J Gorczynski; Mai E Shoman; Carlos Velázquez; Angela Thetford; James B Mitchell; Murali K Cherukuri; S Bruce King; David A Wink
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy.

Authors:  Zhentai Huang; Jianfei Jiang; Natalia A Belikova; Detcho A Stoyanovsky; Valerian E Kagan; Arlan H Mintz
Journal:  J Neurooncol       Date:  2010-09-12       Impact factor: 4.130

6.  Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape.

Authors:  Ryan M Davis; Shingo Matsumoto; Marcelino Bernardo; Anastasia Sowers; Ken-Ichiro Matsumoto; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

7.  Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867.

Authors:  Alex Dayton; Karuppaiyah Selvendiran; Sarath Meduru; Mahmood Khan; M Lakshmi Kuppusamy; Shan Naidu; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  J Pharmacol Exp Ther       Date:  2011-07-28       Impact factor: 4.030

Review 8.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

9.  Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.

Authors:  Iyyapu K Mohan; Mahmood Khan; Sheik Wisel; Karuppaiyah Selvendiran; Arun Sridhar; Cynthia A Carnes; Balazs Bognar; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.